#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Hyperadrenocorticism Congenital ectodermal dysplasia Pulmonary fibrosis Leiomyosarcoma Leukaemia Deafness bilateral Plasma cell myeloma refractory Angiosarcoma recurrent Nephroblastoma Deafness Angiosarcoma Adenocarcinoma gastric Congenital myopathy Angelman's syndrome Partial lipodystrophy More trials…
Learn about Rare Diseases

Optic glioma – Life with Disease Behcet’s syndrome – Life with Disease Prader-Willi syndrome – Basic Information X-linked lymphoproliferative syndrome Wolfram syndrome – Diagnostics Haemolytic uraemic syndrome – Diagnostics Chondrosarcoma metastatic – Basic Information Burkitt’s lymphoma – Treatment Osteosarcoma recurrent – Treatment Brain stem glioma – Trials in Disease More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Omx-0407 [18F]Mc225 GOVORESTAT Gallium (68Ga) Psma-R2 Mva-209-Fsp-B4 Lansoprazole Metoprolol Omaveloxolone Mebufotenin Iopamidol L-SERINE Sar444656 Gadoteridol Milrinone CAL101 Montelukast Mycophenolate Mofetil Topiramate Dersimelagon Phosphate Cobamamide More therapies…

Learn about Your Condition

Crigler-Najjar syndrome Toxicity to various agents Univentricular heart Substance use disorder Endometrial cancer stage I Plasmablastic lymphoma Peritoneal neoplasm Small intestine leiomyosarcoma Cervix carcinoma stage III Hypertriglyceridaemia Pharyngeal cancer stage III Pain Retroperitoneal cancer Neurodegenerative disorder Subdural haematoma More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Neonatal alloimmune thrombocytopenia

Study of Nipocalimab or IVIG for Pregnant Women at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

Recruiting

3 1 1 1
Investigated Diseases:
- Neonatal alloimmune thrombocytopenia
Investigated Drugs:
+5
Study on Nipocalimab for Reducing Risk of Fetal and Neonatal Alloimmune Thrombocytopenia in At-risk Pregnancies

Recruiting

3 1
Investigated Drugs:
- Nipocalimab
+5
Study on the Safety and Effects of RLYB212 in Pregnant Women at Risk for Fetal and Neonatal Alloimmune Thrombocytopenia

Not recruiting

2 1 1
Investigated Diseases:
- Neonatal alloimmune thrombocytopenia
Investigated Drugs:
- Anti-(Integrin Beta-3) Human Monoclonal Antibody

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Neonatal alloimmune thrombocytopenia

Study of Nipocalimab or IVIG for Pregnant Women at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

Study on Nipocalimab for Reducing Risk of Fetal and Neonatal Alloimmune Thrombocytopenia in At-risk Pregnancies

Study on the Safety and Effects of RLYB212 in Pregnant Women at Risk for Fetal and Neonatal Alloimmune Thrombocytopenia

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies